---
title: "InMed Pharmaceuticals Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/aadc3019-30ee-5e00-aa6d-57a6ea7436ec
json: https://whiteintel.dev/api/public/dossier/aadc3019-30ee-5e00-aa6d-57a6ea7436ec
identifier: sec:0001728328
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# InMed Pharmaceuticals Inc.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001728328`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/aadc3019-30ee-5e00-aa6d-57a6ea7436ec  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/aadc3019-30ee-5e00-aa6d-57a6ea7436ec  

## Ownership & control

### Owners / controllers

- **VIVO ASIA OPPORTUNITY FUND, L.P.** (tenpercentowner) — https://whiteintel.dev/entity/4c544e1a-f213-5868-a7b7-f5d83efb3364
- **ADAR1 CAPITAL MANAGEMENT, LLC** (tenpercentowner) — https://whiteintel.dev/entity/1ee00840-ac0e-5918-8ade-9efe3214299f
- **Vivo Opportunity Fund Holdings, L.P.** (tenpercentowner) — https://whiteintel.dev/entity/457c9d0f-90d7-5efb-b1b7-377a2b4ea798
- **Vivo Opportunity, LLC** (tenpercentowner) — https://whiteintel.dev/entity/a59a93fa-4f4e-5933-8687-65027e175174
- **SCHNEEBERGER DANIEL** (tenpercentowner) — https://whiteintel.dev/entity/8f26d25c-5405-5d0e-b639-fc4a106aee70
- **VIVO OPPORTUNITY CAYMAN, LLC** (tenpercentowner) — https://whiteintel.dev/entity/ca2284e1-f909-567d-8c1c-4546a5536b3b
- **ADAMS ERIC A** (tenpercentowner) — https://whiteintel.dev/entity/056d5c49-6f11-58ef-831c-820e59648788

### UBO chain (walk to the ultimate owner)

A **29-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **InMed Pharmaceuticals Inc.** — https://whiteintel.dev/entity/aadc3019-30ee-5e00-aa6d-57a6ea7436ec · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **InMed Pharmaceuticals Inc.**. Human view: https://whiteintel.dev/entity/aadc3019-30ee-5e00-aa6d-57a6ea7436ec · Structured JSON: https://whiteintel.dev/api/public/dossier/aadc3019-30ee-5e00-aa6d-57a6ea7436ec._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._